Medicare billing address
CMS Medicare provider billing file
3400 Spruce St839 West Gates Building
Philadelphia, PA 19104
CMS public data · NPI 1013203579
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Janae K Heath, MD
Specialty
Credential
MD
NPI
1013203579
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Janae K Heath, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3400 Spruce StCMS Doctors & Clinicians file
3737 Market StIn the 2024 CMS provider billing file, this NPI had 337 Medicare beneficiaries and 884 total services. The average beneficiary age was 70, and the average HCC risk score was 2.3.
Total Medicare allowed amount
$42,739.88
Total Medicare payment amount
$32,579.10
Medicare beneficiaries
337
Total services
884
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
72%
CMS beneficiary-panel share
COPD
53%
CMS beneficiary-panel share
Ischemic heart disease
41%
CMS beneficiary-panel share
Chronic kidney disease
35%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Test to measure expiratory airflow and volume | 193 | $8.16 |
| Test to examine how well the lungs exchange gases | 126 | $8.86 |
| Test to determine lung volumes using sensors | 111 | $11.91 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 80 | $119.82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 68 | $16.68 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 67 | $146.40 |
| Test for exercise-induced lung stress | 55 | $22.11 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 32 | $78.09 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 30 | $98.66 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | $31.71 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1013203579. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 122 | 156 | $95,594.63 |
| 2 | Albuterol Sulfate Hfa | Albuterol Sulfate | 119 | 139.7 | $3,942.85 |
| 3 | Montelukast Sodium | Montelukast Sodium | 42 | 68 | $244.05 |
| 4 | Fluticasone Propionate | Fluticasone Propionate | 37 | 59 | $585.59 |
| 5 | Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 32 | 39 | $6,522.15 |
| 6 | Prednisone | Prednisone | 30 | 30.3 | $104.14 |
| 7 | Ipratropium Bromide | Ipratropium Bromide | 28 | 56.7 | $922.01 |
| 8 | Breo Ellipta | Fluticasone/Vilanterol | 27 | 35 | $14,034.47 |
| 9 | Mycophenolate Mofetil | Mycophenolate Mofetil | 25 | 27 | $3,863.87 |
| 10 | Xolair | Omalizumab | 22 | 22 | $40,609.74 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Jefferson Medical College Of Thomas Jefferson University
Graduation year
2011
Group/practice field
University Of Penn - Medical Group
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Critical Care (Intensivists).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.